Clinical trials: All Comers

Retinal Disease, Electroretinogram

RETeval All Comers Trial (REACT)

• Completed
• Age: 6 months to 95 years
• Medical device

The primary objective of this study is to collect electroretinogram ERG measurements from visually normal and abnormal subjects using the FDA cleared RETeval device (K142567).

Trial name

REACT (NCT03065881)

Testing

RETeval

Where

United States

Volunteers

664 people, healthy volunteers welcome

Sponsor

LKC Technologies, Inc.